Li, Huifang published the artcileCorrection to Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor [Erratum to document cited in CA161:328452], Application of Morpholine-4-carbothioamide, the publication is Journal of Medicinal Chemistry (2017), 60(3), 1225, database is CAplus and MEDLINE.
In the original publication on page 6458, The abstract graphic shows the incorrect isomer; the correction is provided here. In the original publication on Page 6460, In line 22 of the right-hand column, the group should be “-OCH3” instead of “-OCHH3“; the correction is provided here. In the original publication, on page 6461,In lines 9 and 35 of the left-hand column, the compound should be “2,4-dibromoimidazole” instead of “4,5-dibromoimidazole”; the correction is provided here. In the original publication, on page 6462, in table 3, the structure for ring A in the compound is incorrect; the correction is provided here. In the original publication on Page 6463, Figure 3D is incorrect; the correction is provided here. In the original publication, ob Page 6464, In the right-hand column in the second line from the bottom, the compound should be “4-(4-(2,4-Dibromo-1Himidazol-1-yl)thiazol-2-yl)morpholine instead of “4-(4-(4,5-Dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine”; the correction is provided here.
Journal of Medicinal Chemistry published new progress about 14294-10-1. 14294-10-1 belongs to amides-buliding-blocks, auxiliary class Morpholine,Thiourea,Amine,Amide, name is Morpholine-4-carbothioamide, and the molecular formula is C5H10N2OS, Application of Morpholine-4-carbothioamide.
Referemce:
https://en.wikipedia.org/wiki/Amide,
Amide – an overview | ScienceDirect Topics